References
- Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370:173–184.
- O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37:138–141.
- O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44:213–218.
- Renom-Guiteras A, Meyer G, Thürmann PA. The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries. Eur J Clin Pharmacol. 2015;71:861–875.
- Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Ärztebl Int. 2010;107:543–551.
- Cahir C, Fahey T, Teeling M, et al. Potentially inappropriate prescribing and cost outcomes for older people: a national population study: potentially inappropriate prescribing in older populations. Br J Clin Pharmacol. 2010;69:543–552.
- Bradley MC, Fahey T, Cahir C, et al. Potentially inappropriate prescribing and cost outcomes for older people: a cross-sectional study using the Northern Ireland enhanced prescribing database. Eur J Clin Pharmacol. 2012;68:1425–1433.
- Al-Omar HA, Al-Sultan MS, Abu-Auda HS. Prescribing of potentially inappropriate medications among the elderly population in an ambulatory care setting in a Saudi military hospital: trend and cost: PIM in Saudi elderly patients. Geriatr Gerontol Int. 2013;13:616–621.
- Morgan SG, Hunt J, Rioux J, et al. Frequency and cost of potentially inappropriate prescribing for older adults: a cross-sectional study. CMAJ Open. 2016;4:E346–E351.
- Harrison SL, Kouladjian O’Donnell L, Milte R, et al. Costs of potentially inappropriate medication use in residential aged care facilities. BMC Geriatr. 2018;18:9.
- Chang C-M, Liu P-Y-Y, Yang Y-HK, et al. Use of the beers criteria to predict adverse drug reactions among first-visit elderly outpatients. Pharmacotherapy. 2005;25:831–838.
- Dalleur O, Spinewine A, Henrard S, et al. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29:829–837.
- Heider D, Matschinger H, Meid AD, et al. Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: retrospective matched cohort study. Drugs Aging. 2017;34:289–301.
- Stockl KM, Le L, Zhang S, et al. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag Care. 2010;16:e1–10.
- Bjerrum L, Rosholm JU, Hallas J, et al. Methods for estimating the occurrence of polypharmacy by means of a prescription database. Eur J Clin Pharmacol. 1997;53:7–11.
- Gnjidic D, Le Couteur DG, Pearson S-A, et al. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;13:115.
- Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725–731.
- Haute Autorité de Santé (HAS). Indicateurs de Pratique Clinique (AMI: alerte Maîtrise Iatrogénie) [Internet]. [ cited 2019 Mar 3]. Available from: https://www.has-sante.fr/portail/jcms/c_1250626/fr/indicateurs-de-pratique-clinique-ipc-pmsa
- Glick HA, Doshi JA, Sonnad SS, et al. Economic evaluation in clinical trials. 1st ed. Oxford; New York: Oxford University Press; 2007.
- Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement ViH. Value Health. 2013;16:e1–e5.
- Blough DK, Madden CW, Hornbrook MC. Modeling risk using generalized linear models. J Health Econ. 1999;18:153–171.
- Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–494.
- Sönnerstam E, Sjölander M, Gustafsson M. An evaluation of the prevalence of potentially inappropriate medications in older people with cognitive impairment living in Northern Sweden using the EU(7)-PIM list. Eur J Clin Pharmacol. 2017;73:735–742.
- Mucalo I, Hadžiabdić MO, Brajković A, et al. Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol. Eur J Clin Pharmacol. 2017;73:991–999.
- Grina D, Briedis V. The use of potentially inappropriate medications among the lithuanian elderly according to beers and EU(7)-PIM list - a nationwide cross-sectional study on reimbursement claims data. J Clin Pharm Ther. 2017;42:195–200.
- Hosmer DW, Hosmer T, Le Cessie S, et al. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16:965–980.
- Copas JB. Regression, prediction and shrinkage. J R Stat Soc Series B Stat Methodol. 1983;45:311–354.
- Bo M, Gibello M, Brunetti E, et al. Prevalence and predictors of inappropriate prescribing according to the screening tool of older people’s prescriptions and screening tool to alert to right treatment version 2 criteria in older patients discharged from geriatric and internal medicine wards: A prospective observational multicenter study. Geriatr Gerontol Int. 2019;19:5–11.
- Cool C, Cestac P, Laborde C, et al. Potentially inappropriate drug prescribing and associated factors in nursing homes. J Am Med Dir Assoc. 2014;15:850.e1–e9.
- Moriarty F, Bennett K, Fahey T, et al. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol. 2015;71:473–482.
- Pohl-Dernick K, Meier F, Maas R, et al. Potentially inappropriate medication in the elderly in Germany: an economic appraisal of the PRISCUS list. BMC Health Serv Res. [Internet]. 2016 [cited 2017 Sep 14]; 16. Available from: http://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-016-1366-x.
- O’Connor MN, O’Sullivan D, Gallagher PF, et al. Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016;64:1558–1566.